Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Ingrid Kristensen"'
Autor:
Filipa Sampaio, Ulrica Langegård, Patricio Martínez de Alva, Sergio Flores, Camilla Nystrand, Per Fransson, Emma Ohlsson-Nevo, Ingrid Kristensen, Katarina Sjövall, Inna Feldman, Karin Ahlberg
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background This study assessed the cost-effectiveness of proton beam therapy (PBT) compared to conventional radiotherapy (CRT) for treating patients with brain tumors in Sweden. Methods Data from a longitudinal non-randomized study performed
Externí odkaz:
https://doaj.org/article/a3f40d8045ec42289fbbd1bd0815d1ff
Autor:
Peter Lægdsmand, Witold Matysiak, Ludvig P. Muren, Yasmin Lassen-Ramshad, John H. Maduro, Anne Vestergaard, Roberto Righetto, Erik Pettersson, Ingrid Kristensen, Pauline Dutheil, Charlotte Demoor-Goldschmidt, Frances Charlwood, Gillian Whitfield, Marta M. Feijoo, Anthony Vela, Fernand Missohou, Sabina Vennarini, Alfredo Mirandola, Ester Orlandi, Barbara Rombi, Anneleen Goedgebeur, Karen Van Beek, Agata Bannink-Gawryszuk, Fernando C. Campoo, Jacob Engellau, Laura Toussaint
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 32, Iss , Pp 100675- (2024)
Background and Purpose: Radiotherapy for paediatric posterior fossa tumours may cause complications in the brainstem and upper spinal cord due to high doses. With proton therapy (PT) this risk may increase due to higher relative biological effectiven
Externí odkaz:
https://doaj.org/article/4a9b1aecd3d84ee3b706b318f68f923f
Autor:
Kristin Kunni, Ulrica Langegård, Emma Ohlsson-Nevo, Ingrid Kristensen, Katarina Sjövall, Per Fessé, Linda Åkeflo, Karin Ahlberg, Per Fransson
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 31, Iss , Pp 100269- (2024)
Background and purpose: Since patients with primary brain tumor are expected to become long-term survivors, the prevention of long-term treatment-induced side effects is particularly important. This study aimed to explore whether symptom experience a
Externí odkaz:
https://doaj.org/article/c93454e4b2f14729ba6d63de5f4eaeab
Autor:
Filip Hörberger, Karin M. Andersson, Marika Enmark, Ingrid Kristensen, Anna Flejmer, Anneli Edvardsson
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Purpose/background: The aim of this study was to evaluate pencil beam scanning (PBS) proton therapy (PT) in deep inspiration breath-hold (DIBH) for mediastinal lymphoma patients, by retrospectively evaluating plan robustness to the clinical target vo
Externí odkaz:
https://doaj.org/article/757ac31ba5ec40f08cc5bff7dd2ab97a
Autor:
Inge C Olsen, Thomas Henry, Corina Silvia Rueegg, Asgeir S Jakola, Hanne Blakstad, Petter Brandal, Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander, Cecilie Kiserud, Tonje Haug Nordenmark, Taran Paulsen Hellebust, Morten Egeberg Evensen, Magnus Gustavsson, Christina Ramberg, Mette Sprauten, Henriette Magelssen, Janani Moorthy, Karin Andersson, Ingela Raunert, Cecilie Moe, Carin Granlund, Dorota Goplen, Jorunn Brekke, Tor-Christian Aase Johannessen, Tora Skeidsvoll Solheim, Kirsten Marienhagen, Øyvind Humberset, Per Bergström, Måns Agrup, Ludvig Dahl, Michael Gubanski, Helene Gojon, Carl-Johan Brahme, Isabelle Rydén, Einar O Vik-Mo, Hanne C. Lie, Lars Asphaug, Maziar Hervani, Ingrid Kristensen, Rolf J Ledal, Eskil Degsell, Katja Werlenius, Malin Blomstrand
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction The use of proton therapy increases globally despite a lack of randomised controlled trials demonstrating its efficacy and safety. Proton therapy enables sparing of non-neoplastic tissue from radiation. This is principally beneficial and
Externí odkaz:
https://doaj.org/article/a71f1463c05244a9a4ac7eb02407367a
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 13, Iss , Pp 6-10 (2020)
Background: Most patients with Hodgkin’s lymphoma are young and have a favourable prognosis, therefore it is of high importance to decrease the radiation doses to normal tissues received during radiotherapy. A combination of proton therapy and deep
Externí odkaz:
https://doaj.org/article/b6df17bf86554e468d9441aae9b4d943
Autor:
Caroline Olsson, Tufve Nyholm, Elinore Wieslander, Eva Onjukka, Adalsteinn Gunnlaugsson, Johan Reizenstein, Stefan Johnsson, Ingrid Kristensen, Johan Skönevik, Magnus Karlsson, Ulf Isacsson, Anna Flejmer, Edvard Abel, Fredrik Nordström, Leif Nyström, Kjell Bergfeldt, Björn Zackrisson, Alexander Valdman
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 11, Iss , Pp 88-91 (2019)
A fundamental problem in radiotherapy is the variation of organ at risk (OAR) volumes. Here we present our initial experience in engaging a large Radiation Oncology (RO) community to agree on national guidelines for OAR delineations. Our project buil
Externí odkaz:
https://doaj.org/article/c2136910012b45ebab9be044271c8f0d
Autor:
Ingrid Kristensen, Kristina Nilsson, Måns Agrup, Karin Belfrage, Anna Embring, Hedda Haugen, Anna-Maja Svärd, Tommy Knöös, Per Nilsson
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 3, Iss C, Pp 41-47 (2017)
Background and purpose: Substantial inter-observer variations in target delineation have been presented previously. Target delineation for paediatric cases is difficult due to the small number of children, the variation in paediatric targets, the num
Externí odkaz:
https://doaj.org/article/856c75c6b3c04d0da4a4284c2da10006
Autor:
Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander, Cecilie Kiserud, Tonje Haug Nordenmark, Taran Paulsen Hellebust, Morten Egeberg Evensen, Magnus Gustavsson, Christina Ramberg, Mette Sprauten, Henriette Magelssen, Hanne Blakstad, Janani Moorthy, Karin Andersson, Ingela Raunert, Thomas Henry, Cecilie Moe, Carin Granlund, Dorota Goplen, Jorunn Brekke, Tor-Christian Aase Johannessen, Tora Skeidsvoll Solheim, Kirsten Marienhagen, Øyvind Humberset, Per Bergström, Måns Agrup, Ludvig Dahl, Michael Gubanski, Helene Gojon, Carl-Johan Brahme, Isabelle Rydén, Asgeir S Jakola, Einar O Vik-Mo, Hanne C. Lie, Lars Asphaug, Maziar Hervani, Ingrid Kristensen, Corina Silvia Rueegg, Inge C Olsen, Rolf J Ledal, Eskil Degsell, Katja Werlenius, Malin Blomstrand, Petter Brandal
Publikováno v:
BMJ Open. 13:e070071
IntroductionThe use of proton therapy increases globally despite a lack of randomised controlled trials demonstrating its efficacy and safety. Proton therapy enables sparing of non-neoplastic tissue from radiation. This is principally beneficial and